The World Market for Point of Care (POC) Diagnostics
NEW YORK, Jan. 29, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Point-of-care (POC) tests are diagnostic tests that are performed at or near the site where the patient is located. They are performed in decentralized settings, outside of central hospital laboratories or centralized reference laboratories. Growth in POC testing is being fueled by many factors including the growing number of people with diabetes, the globalization of infectious diseases and the associated public health issues, advances in therapies giving physicians more tools for treatment of patients if the doctor is able to rapidly diagnose the problem, the need to monitor an ever-growing group of people with chronic diseases such as cardiovascular diseases, arthritis, cancer and other chronic conditions, and many other factors.
Point of Care Testing (POCT) is attracting considerable investor and industry activity. This Kalorama Information report, The World Market for Point of Care Diagnostics, the result of primary and secondary research into the point of care diagnostics market, presents the most current analysis of the POC Diagnostics industry and the role it plays in medical practice. This report takes an in depth look at the market, technologies, and trends in decentralized testing, looking at both self-testing by patients (also referred to as the over-the-counter (OTC) market, and at point-of-care testing by healthcare professionals.
As part of this report's coverage, the following data is included:
- Molecular POC Test Products and the Future of Molecular POC
- Self-Testing Point of Care Test Market by Category, Worldwide (Glucose, Infectious Diseases, Critical Care, Cardiac Markers, Hematology, Coagulation, Fecal Occult Blood, HbA1c, Cholesterol/Lipids, Drugs of Abuse, Pregnancy/Ovulation, Other)
- Professional Point of Care Testing Market by Test Category, Worldwide, 2011 and 2016 (Glucose, Pregnancy/Ovulation, Fecal occult blood, Coagulation, Drugs of abuse, Cholesterol, HIV, Other)
- Regional Breakout of POC Market (US, EU, Japan, ROW)
- Blood Glucose Monitoring Markets
- Small Footprint and POC Chemistry Systems
- Small Footprint and POC Hematology Systems
- Small Footprint and POC Immunoassay Systems
- Non-Invasive Testing Innovations
- Miniaturization and Microfluidics Innovations
- POC Test Revenues of Selected IVD Companies
- Selected Rapid HIV Tests on the Market
- Comparative Effectiveness, Healthcare Reform and Other Trends in IVD
- Hospital POCT, Physician Office POCT, Critical Care POCT
All countries are feeling the brunt of aging populations and an increased burden of chronic disease management. Employers and insurance companies are interested in improving the health of customers, and there are some innovative tactics developing in this area. The report is conservative in its predictions and offers a calculated look into the future, based on events currently taking place.
The field for rapid test devices is crowded. This report profiles 140 companies that currently market POC, plus more than 40 additional companies that are developing POC technologies and products or that have just recently entered this market. Companies profiled in this report are using a wide range of different technologies to develop and market rapid tests for much of the range of in vitro diagnostic (IVD) tests that can be performed in centralized laboratories.
The report offers a quantitative assessment of specific markets, worldwide, in U.S. dollars for 2011 to 2016. Information is provided in order to set the status quo of tests and technologies, and to get a look at what is coming. The report also discusses how these tests will affect the economics of healthcare over the near term and longer when possible.
CHAPTER ONE: EXECUTIVE SUMMARY
Size of POC Market
CHAPTER TWO: INTRODUCTION
Introduction and Definitions
Advantages and Disadvantages of Point-of-Care Testing
CHAPTER THREE: TECHNOLOGY INNOVATIONS IN POINT-OF-CARE TESTING
Miniaturization and Microfluidics Technologies
CHAPTER FOUR: LOCATIONS FOR POINT-OF-CARE TESTING
POC Testing in Hospitals and Clinics
Physicians' Office Laboratories
Other Professional POC Testing
Home Monitoring - Telemedicine
Home Self Testing
CHAPTER FIVE: POINT-OF-CARE TESTING MARKET ANALYSIS
Market Overview POC Markets – Current Markets and Market Forecasts
CHAPTER SIX: POINT-OF-CARE MARKET SEGMENTS
Diabetes Pregnancy and Ovulation
POC Testing Market of the Future - Molecular Diagnostics
CHAPTER SEVEN: HEALTHCARE ECONOMICS AND HEALTHCARE REFORM
Heathcare Economics and Outcomes Testing Healthcare Reform
CHAPTER EIGHT: COMPANY PROFILES – COMPANIES MARKETING POC TEST PRODUCTS
1 Step Detect Associates
77 Elektronika Kft.
A. Menarini Diagnostics
AccuBioTech Co., Ltd.
Advanced Care Products
Advanced Microdevices Pvt. Ltd.
Alfa Scientific Designs, Inc.
Alfa Wassermann Diagnostic Technologies, LLC
Alliance International Co., Ltd.
American Bio Medica Corp
American Screening Corporation
Analyticon Biotechnologies AG
Ani Biotech/Ani Laboratories
Apex Biotechnology Corp.
Arlington Scientific, Inc.
AspenBio Pharma, Inc.
Atlas Link Biotech Co., Ltd.
Autobio Diagnostics Co., Ltd.
Bayer Diabetes Care
Beckman Coulter Inc.
Becton, Dickinson and Company (BD)
BioAssay Works, LLC
BioLand Technology Ltd.
bioLytical Laboratories Inc.
Biomagnetics Diagnostics Corporation
Bioptik Technology, Inc
Bio-Rad Laboratories Inc.
BioSence Medical Devices
BioSys Laboratories, Inc.
Blue Cross Biomedical Company
Boditech Med Inc.
BodyTel Scientific, Inc.
Boson Biotech Co., Ltd.
Branan Medical Corporation
Calypte Biomedical Corporation
Cambridge Sensors Ltd. and/or Cambridge Sensors USA
CERAGEM Medisys Inc.
Chembio Diagnostic Systems, Inc.
Clinical Innovations, LLC
CTK Biotech Inc.
DENKA SEIKEN CO., LTD.
DFI Co., Ltd.
Diabetes Sentry Products Inc.
Diagnostics for All (DFA)
Diagnostics for the Real World (DRW)
DiaSys Diagnostic Systems
Echo Therapeutics, Inc.
Enigma Diagnostics Limited
Entra Health Systems
Epinex Diagnostics Laboratories, Inc.
EUMED Biotechnology Co. Ltd.
General Biologicals Corp.
Heidelberger-Medical-Marketing GmbH (HMM GmbH)
Helena Laboratories USA
Hema Diagnostic Systems
HemoCue, Inc. A Quest Diagnostic Company
Horiba ABX S.A.
inBios International Inc.
Innovative Biosensors, Inc.
Integrity Applications Ltd.
International Technidyne Corp (ITC)
Inverness Medical Innovations
Liming Bio-products Co., Ltd.
Metaara Medical Technologies Inc
microfluidic ChipShop GmbH
Micropoint Bioscience, Inc.
MP Biomedicals LLC
MycroLab Pty Ltd.
Network Biosystems, Inc. (NetBio)
Nexus Dx, Inc. (Subsidiary of Samsung Electronics Co.)
Noninvasive Medical Technologies, Inc.
OPTI Medical Systems, Inc.
OraSure Technologies, Inc.
Ortho Clinical Diagnostics
pes diagnosesysteme GmbH
Polymer Technology Systems, Inc.
Princeton Biomeditech Corp
Probe Scientific Ltd
Prodigy Diabetes Care
Propper Manufacturing Co.
QuikTest USA, Inc.
Rapid Pathogen Screening
ReLIA Diagnostic Systems
Response Biomedical Corp.
Siemens Healthcare Diagnostics
POC Sales by Test Category, Worldwide
World Glucose Monitoring Sales by Company
Selected Continuous Blood Glucose Monitoring Systems
Selected OTC Pregnancy and Ovulation Tests
Selected POC Clinical Chemistry Systems
Selected Urinalysis POC Tests
Selected POC Blood Gas Systems
Selected Rapid Infectious Disease Tests
Selected POC Coagulation Tests
Selected Molecular Diagnostic Companies Targeting Rapid or POC Market
To order this report:
Contact Nicolas: firstname.lastname@example.org
Intl: +1 805-652-2626